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Abstract Ribonucleotide reductase (RR) is an attractive drug 
target molecule. The gene of the R2 protein of Trypanosoma 
brucei RR (nrd 17) has been cloned. It encodes a protein of 337 
residues which shows about 60% identity with other eukaryotic 
R2 proteins. All residues which bind the iron center, the tyrosyl 
radical or are supposed to participate in the radical transfer are 
conserved in the trypanosomal protein sequence. Overexpression 
of the gene in E. coli resulted in 2-5 mg pure R2 protein from 100 
ml bacterial cell culture. Northern blot analysis revealed a 
transcript of 1.85 kb in bloodstream and procyclic forms of the 
parasite. 
© 1997 Federation of European Biochemical Societies. 
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As a first step towards the understanding of the trypanoso- 
mal synthesis of deoxyribonucleotides we describe the cloning 
of the gene of r ibonucleotide reductase subunit R2 from 72 
brucei hrucei and its overexpression i E. coli. 
2. Materials and methods 
2.1. DNA and RNA preparation 
2;4 l08 long slender 72 brucei cells were suspended in 10 mM Tris- 
HC1, 250 mM NaCI, 0.5% Nonidet P-40, pH 8.0. After 5 rain incu- 
bation on ice the suspension was centrifuged and the cell pellet was 
homogenized in 200 lal 10 mM Tris-HC1, 10 mM NaC1, 10 mM 
EDTA, 0.5% SDS, pH 8.0. 50 lag proteinase K were added and the 
mixture was incubated for 1 h at 37°C. DNA was purified by phenol 
extraction. 
RNA was isolated from bloodstream long slender and short stumpy 
as well as procyclic stages of 72 brucei using the RNA Easy Kit 
(Qiagen) according to the instructions of the manufacturer. 
1. Introduction 
Trypanosomes are the causative agents of Afr ican sleeping 
sickness (Trypanosoma brucei rhodesiense, T. b. gambiense), 
South American Chagas'  disease (T. cruzi) and nagana cattle 
disease (72 congolense, T. vivax). The parasites possess a 
unique thiol metabolism. Instead of glutathione/glutathione 
reductase they have a trypanothione/trypanothione reductase 
system [1,2]. Since in all known eukaryotes the synthesis of 
deoxyribonucleotides catalyzed by ribonucleotide reductase 
(RR, E.C. 1.17.4.1.) is a thiol dependent process [3,4] the 
question raises if the unique dithiol trypanothione is involved 
in the parasite synthesis of DNA precursors. 
Eukaryotic r ibonucleotide reductases are tetrameric cc2132 
proteins [5,6]. The large c~ subunit (R1) is responsible for 
substrate and effector binding. A thiyl radical in RI is directly 
involved in catalysis. It is formed by long-range radical trans- 
fer from a tyrosyl radical of the small [3 subunit (R2). This 
tyrosyl radical is generated by an oxygen-bridged di-iron cen- 
ter that is also localized in the small subunit [6,7]. Each sub- 
unit is inactive when assayed individually [3-7]. 
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R2, subunit [3 of RR; nrd B, gene encoding R2 of ribonucleotide 
reductase; 22 b., Trypanosoma brueei; IPTG, isopropyl-[]-D-thiogalac- 
topyranoside: Ni-NTA, Ni-nitriloacetic acid 
The gene sequence of the R2 protein of 22 brucei ribonucleotide 
reductase has been deposited in the EMBL Nucleotide Sequence 
Database (accession o. Y10768). 
2.2. Isolation oj the 22 brucei nrd B gene 
Total RNA of long slender bloodstream T. hrucei was reverse tran- 
scribed into single-stranded cDNA using Moloney murine leukemia 
virus reverse transcriptase and an oligo(T) primer [5'-GACTC- 
GAGTCGACATCGATTTTTTTTTTTTTTTTT(G/C/A )]. 
Primers for PCR were derived from consensus sequences of eukary- 
otic R2 proteins. An internal fragment of R2 was amplified from the 
cDNA with two oligonucleotides [5'-GCIGCIAGCGACGGCATTG- 
TGAACGA(A/G)AA and 5'-GCGGTCCACAAACTCGATG TA(C/ 
T)TG] (95°C, 5 min; 30 cycles: 95°C, 1 rain, 45°C, 1 min; 72°C, 1 
min). For cloning the 5' end of the gene a gene specific primer [5'- 
AGGGATATTTT CCATAGCAATCTGGAACCC (A / G)TA(A / G)- 
AA] and a spliced leader specific primer (5'-TAGAACAGTTTCTG- 
TACTATATTG) were used in a modified 5' RACE-PCR (95°C 
2 rain; 25 cycles: 95°C, 30 s; 55°C, 1 rain; 72°C, 1 min). The 3' 
end was amplified (95°C, 2 min; 25 cycles: 94°C, 1 min; 50°C, 
1 min; 72°C, 30 s) using the oligo(T) and a gene specific primer (5'- 
ATTGGAATGAATTCTCAG). 
The complete gene was obtained from genomic DNA using a 3' 
primer which contained an additional XhoI cleavage site (5'-GT- 
GTCTCGAGCACCAACGATAACATCCCTA) and a 5' primer 
(5'-ACAGAATTCAAACGATGCCACCCAAATCTCACAA). PCR 
was carried out with PJu polymerase (95°C, 5 min; 30 cycles: 94°C, 
1 min; 45°C, 1 min; 72°C, 3 min). The PCR products were cloned 
into the pBluescript SK(+) vector (Stratagene) for sequencing. 
2.3. DNA sequencing 
DNA was sequenced by the dideoxynucleotide chain-termination 
method using the T4 Sequencing Kit (Pharmacia Biotech). Both 
strands were completely sequenced. 
2.4. Expression of 22 b. brucei nrd B in E. coli 
The gene of 72 b. brucei R2 was excised from the pBluescript vector 
by XhoI digestion and subcloned into the SalI site of the pQE-31 
vector. This construct encodes the R2 protein with a 34 residues 
long N-terminal extension containing a His6- Tag. Competent E. 
coil SG13009 were transformed with the pQE/His-nrd B plasmid. A 
25 ml culture of recombinant cells in 2 x YT medium supplemented 
with 100 lag/ml carbenicillin and 25 lag/ml kanamycin was grown at 
37°C to an OD~;00 of 0.8. Expression was induced with 1 mM IPTG 
for 4 h at 37°C. The protein was chromatographed on Ni-NTA Se- 
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T. b ruce i  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
human MLSLRVPLAP ITDPQQLQLS PLKGLSLVDK ENTPPALSGT RVLASKTARR 50 
mouse  MLSVRTPLAT IADQQQLQLS PLKRLTLADK ENTPPTLSST RVLASKAARR 50 
P. fa lc ip  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  MADVIN ISR I  i0 
E. co l i  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
T. b ruce i  .... MPPKSH KRSRKEGEVE EPLLTENPDR YV IFP IKYPD 
human IFQEPTEPKT KAAA. PGVED EPLLRENPRR FV IFP IEYHD 
mouse  IFQDSAELES KAPTNPSVED EPLLRENPRR FVVFP IEYHD 
P. fa lc ip .  P IFSKQEREF SDLQKGKEIN EK ILNKESDR FTLYP ILYPD 
E. co l i  . . . . . .  AYTT FSQTKNDQLK EPMFFGQPVN VARYDQQKYD 
IWQ.KYKKAE 45 
IWQ.MYKKAE 98 
IWQ.MYKKAE 99 
VWD.FYKKAE 59 
IFEKL IEKQL 44 
# 
[] 0 
T. b ruce i  SSIWTVEEID LGNDMTDWEK LDDGERHFIK  HVLAFFAASD 
human ASFWTAEEVD LSKDIQHWES LKPEERYF IS  HVLAFFAASD 
mouse  ASFWTAEEVD LSKDIQHWEA LKPDERHFIS  HVLAFFAASD 
P. fa lc ip .  ASFWTAEEID LSSDLKDFEK LNENEKHFIK  HVLAFFAASD 
E. co l i  SFFWRPEEVD VSRDRIDYQA LPEHEKHIF I  SNLKYQTLLD 
GIVLENLAER 95 
G IVNENLVER 148 
G IVNENLVER 149 
G IVLENLAS K 109 
S IQGRSPNVA 94 
# # 
D * 
T. b ruce i  FMCEVQVPEV RCFYGFQIAM ENIHSET¥SV L IDTYVVDPD EKQRLLHAIR  145 
human FSQEVQITEA RCFYGFQIAM ENIHSEMYSL  L IDTY IKDPK EREFLFNAIE  198 
mouse FSQEVQVTEA RCFYGFQIAM ENIHSEMYSL  L IDTY IKDPK EREYLFNAIE  199 
P, fa l c ip .  FLREVQITEA KKFYSFQIAV ENIHSETYSL  L IDNYIKDEK ERLNLFHAIE  159 
E. co l i  LLPL IS IPEL  ETWVETWAFS ETII ISRSYTH I IRN IVNDPS . . .VVFDDIV  141 
T. b ruce i  T IPC IEKKAK . . . . . . . . . . . . .  WAIEWIG .SQTSFPTRL  VAFA ...... 175 
human TMPCVKKKAD . . . . . . . . . . . . .  WALRWIG DKEATYGERV VAFA ...... 229 
mouse  TMPCVKKKAD . . . . . . . . . . . . .  WALRWIG DKEATYGERV VAFA ...... 230 
P. fa lc ip .  NIPAVKNKAL . . . . . . . . . . . . .  WAAKWIN DTN.SFAERI  VANA ...... 189 
E• co l i  TNEQIQKRAE G ISSYYDEL I  EMTSYWHLLG EGTHTVNGKT VTVSLRELKK 191 
Fig. 1. Amino acid sequences of R2 proteins. The derived protein sequence of 72 brucei RR subunit 2 is aligned with that of human (accession 
number P31350; ref. [9]), mouse (Pl1157; ref. [10]), Plasmodium falciparum (P50650; ref. [11]) and E. coli R2 (P00453; ref. [12]). 16 Residues 
(bold letters) are invariant in all R2 proteins sequenced so far (Asp139 is a Glu in the Epstein-Barr virus protein). Most of them are iron 
ligands (#), form the hydrophobic pocket (+) around the tyrosyl radical (*) or are proposed to be involved in the electron transfer mech- 
anism (13). 
pharose in the presence and absence of 8 M urea according to the 
instructions of the manufacturer (Qiagen). The denatured protein was 
eluted from the column with 100 mM EDTA, the native protein with 
250 mM imidazol. 
2.5. Northern blot analysis 
10 ~g total RNA from long slender, short stumpy and procyclic 
72 brucei cells was electrophoresed on a 1% agarose gel containing 
5°/% formaldehyde and transferred to a GeneScreen Plus membrane 
(NEN/Dupont) by capillary blot with 1.5 M sodium chloride, 
0.15 M sodium citrate, pH 7.0 (10xSSC). The membrane was hy- 
bridized overnight with randomly primed [c~-Pa2]dCTP radiolabeled 
complete nrd B in 250 mM NaH2PO4, 1 mM EDTA, 7% SDS at 
68°C. After washing the membrane with 2 x SSC, 0.5% SDS followed 
by 0.1 x SSC, 0.5% SDS, signals were quantified on a Fuji Phosphor- 
imager. Equivalent amounts of RNA were loaded as determined 
by methylen blue staining and hybridization with a T. brucei actin 
probe. 
3. Results and discussion 
3.1. Cloning and sequencing of  T. brucei ribonucleotide 
reductase nrd B 
An internal fragment of the gene (position 244-828) coding 
for ribonucleotide reductase subunit 2 (nrd B) was isolated 
from T. brucei cDNA by PCR using primers which repre- 
sented highly conserved regions of eukaryotic R2 proteins. 
For amplifying the 3'- and 5'-ends of the gene a poly(T) 
primer and a spliced leader primer, respectively each in com- 
bination with a gene specific oligonucleotide were used. The 
spliced leader is the very 5' end of all trypanosomal mRNAs 
which is added by trans-splicing [8]. 
The complete gene of T. b. brucei R2 was isolated from 
genomic DNA by PCR and sequenced. An open reading 
M. Dormeyer et aL/FEBS Letters 414 (1997) 449-453 
# # # 
+ + + D 
T. b ruce i  . . . . . . . . . .  AVEGIFFSGS FCAIFWLKKR GLMPGLTFSN EL ISRDZGLH 215 
human . . . . . . . . . .  AVEGIFFSGS FAS IFWLKKR GLMPGLTFSN EL ISRDZGLH 269 
mouse  . . . . . . . . . .  AV~GIFFSGS FAS IFWLKKR GLMPGLTFSN EL ISRDEGLH 270 
P. fa lc ip  . . . . . . . . . . .  CVEGILFSGS FCAIFWFKKQ NKLHGLTFSN EL ISRDEGLH 229 
E. co l i  KLYLCLMSVN AL~IRFYVS FACSFAFAER ELMEGNAKI I  RL IARDEALH 241 
451 
T. b ruce i  . TDFACLLYE KY IVNKLPR . . . . . . . . . .  DR VLE I ICNAVS IEREF ICDAL 255 
human .CDFACLMF.  KHLVHKPSE . . . . . . . . .  ER VRE I I INAVR IEQEFLTEAL  308 
mouse  .CDFACLMF.  KHLVHKPAE . . . . . . . . .  QR VRE I ITNAVR IEQEFLTEAL  309 
P. fa lc ip .  .TDFNCLIY.  SLLDNKLPE . . . . . . . . .  QI IQNIVKEAVE VERSF ICESL  268 
E. co l i  LTGTQHMLNL LRSGADDPEM AE IAEECKQE CYDLFVQAAQ QEKDWADYLF  291 
T. b ruce i  P .VRL IGMNS QLMTQYIEFV ADRLLVSLGY DRHYNSK.NP  FDFMD. .MIS  301 
human P .VKL IGMNC TLMKQYIEFV ADRLMLELGF SKVFRVE.NP  FDFME. .N IS  354 
mouse  P .VKL IGMNC TLMKQYIEFV ADRLMLELGF NK IFRVE.NP  FDFME. .N IS  355 
P. fa lc ip .  P .CDL IGMNS RLMSQYIEFV ADRLLECLGC SK IFHSK.NP  FNWMD. .L IS  314 
E. co l i  RDGSMIGLNK D ILCQYVEY I  TN IRMQAVGL DLPFQTRSNP IPWINTWLVS 341 
D [] 
T. b ruce i  LQGKTNFFEK KVGEYQKAGV 
human LEGKTNFF~K RVGEYQRMGV 
mouse  LEGKTNFFZK RVGEYQRMGV 
P. fa lc ip ,  LQGKTNFFEK RVADYQKSGV 
E. co l i  DNVQVAPQZV EVSSYLVGQI  
Fig. 1. 
frame of 1011 bp corresponds to a deduced protein sequence 
of 337 amino acid residues with a calculated molecular weight 
of 39.060. 
3.2. Sequence comparison of 72 brucei R2 with other R2 
proteins 
The deduced amino acid sequence of the T. brucei gene 
shares about 60°/,, identity with the RR subunit 2 of other 
eukaryotes but only 20% with the E. coli enzyme. The amino 
ends of R2 proteins vary considerably in length between dif- 
ferent species. The T. brucei protein is about 50 residues hort- 
er than mammalian and yeast enzymes as are those of plants, 
viruses, plasmodia and E. coli. The N-terminal amino acid 
sequence of T. brucei R2 is very hydrophilic. 8 out of the first 
11 residues are positively charged or neutral hydrophilic. 
Residues which bind the binuclear iron center interact with 
the tyrosyl radical or participate in the radical transfer to 
subunit 1 are invariant within the R2 protein family (Fig. 
1). Asp85, Glu116, His119, Glu178, Glu212 and His215 cor- 
respond to the iron ligands in mouse and E. coli R2 [7,13,14]. 
Tyr123 (Tyrl22 in the E. coli enzyme) forms the radical 
which is essential for catalysis [13]. Three invariant residues 
(Phe182, Phe186, and Ile208) create a hydrophobic pocket 
around the tyrosine and are supposed to stabilize the radical. 
Other residues in the vicinity of the tyrosine are not strictly 
conserved. As outlined by Kauppi et al. [14] the tyrosine en- 
vironment in mouse R2 is more hydrophobic than that in the 
E. coli enzyme since two Phe and a Met replace a Tyr, Gln 
MSSERSSKVF SLDADF.336 
MSS.PTENSF TLDADF.389 
MSN.STENSF TLDA/)F.390 
MA.QRKDQVF CLNTEF .349 
DSEVDTDDLS NFQL. . .375  
( Contmue~ 
and Set. In the 72 brucei sequence, Phe80, Phe81 and Thr122 
occupy the respective positions. Interestingly, in lower eukar- 
yotes a threonine precedes the catalytic tyrosine whereas in 
higher organisms this residue is Met. 
All residues which participate in the radical transfer to the 
active site in subunit RI,  namely Trp49, Asp85, Hisl l9,  
Asp211, Glu310, and Tyr316 [5,15,16] are conserved. These 
findings suggest hat the mechanism of ribonucleotide r duc- 
ss Is pc 
,1850 nt 
Fig. 2. Expression of T. brucei R2 mRNA in different developmen- 
tal stages. Total RNA of long slender (Is) and short stumpy (ss) 
bloodstream and procyclic (pc) insect forms of T. brucei was puri- 
fied, separated and blotted as described under Section 2. The mem- 
brane was hybridized with the full length :~2p-labelled nrd B probe. 
A single transcript of 1850 nt is recognized. Subsequent s ripping 
and hybridization with a T. brucei actin probe confirmed that equal 
amounts of RNA were present in the three samples. The complete 
Northern blot covered RNA molecules between > 10000 and < 100 
bases. Since there was no additional band and the signal to noise 
ratio for the R2 transcript was >> 100:1 only the relevant section of 
the blot is depicted. 
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tion in the trypanosomal enzyme is similar to that of E. coli 
RR. The conclusion is in accordance with the sensitivity of 
trypanosomes towards hydroxyurea [17-19] although at low 
concentrations of hydroxyurea inhibition of ribonucleotide 
reductase seems not to be the primary effect [19]. The sensi- 
tivity of ribonucleotide reductases from different species to- 
wards radical scavengers varies r markably and may be due to 
the accessibility of the iron/radical center [14]. In the E. coli 
enzyme a channel which connects the surface with the pro- 
posed oxygen reaction site is shielded by a tyrosine residue. In 
contrast, nearly all eukaryotic proteins have a serine at this 
position (Ser183 in T brucei R2). 
Interaction between the R1 and R2 proteins is entirely ac- 
counted for by the carboxy terminus of the small subunit 
[15,20]. Synthetic peptides containing the seven C-terminal 
residues of R2 are selective inhibitors of mammalian [20], viral 
[21] and probably plasmodial [22] ribonucleotide r ductases. 
The C-terminal heptapeptide of T. brucei R2 differs by only 
one Ser/Thr exchange from that of the human enzyme which 
probably excludes elective inhibition of the parasite nzyme. 
The heptapeptide can now be used for the preparation of an 
affinity matrix for purifying the R1 subunit from the parasites 
[20]. 
3.3. Expression of T. brucei nrd B in E. coli 
The nrd B gene was cloned into the pQE expression vector. 
The construct encodes the R2 protein with a 34 residues long 
N-terminal extention containing a His6 sequence. E. eoli cells 
were transformed with the plasmid and expression of the gene 
was induced with IPV~. The recombinant protein was purified 
on Ni-NTA Sepharose. SDS-PAGE under reducing condi- 
tions revealed a single protein band with a Mr of approxi- 
mately 42 kDa. From a 100 ml culture of recombinant E. coli 
cells 2-5 mg of protein were purified. Difference absorption 
spectra of native and hydroxy urea-treated R2 purified under 
non-denaturing conditions revealed the presence of the char- 
acteristic tyrosyl radical in about 5% yield [23]. 
3.4. Northern blot analysis 
Total RNA from long slender, short stumpy, and procyclic 
T. brucei was separated and probed with the complete nrd B. 
Long slender parasites are the blood stream forms which are 
capable of division. Short-stumpy forms do not divide and 
represent a form with a metabolism intermediate between 
that of the long slender and the procyclic forms that multiply 
in the tse-tse fly. A single RNA transcript of 1.85 kb was 
recognized in all three developmental stages of the parasite 
(Fig. 2) whereby the hybridization signal was 27% higher in 
the short stumpy forms when compared to long slender and 
procyclic forms. The mRNA is about 0.8 kb larger than the 
gene. This is due to 82 nt at the 5' end which include the 
spliced leader sequence and a long 3' untranslated region 
[24]. The slightly higher mRNA level in the short stumpy 
forms does not seem to be significant, but it clearly shows 
that the mRNA is not down-regulated although these cells 
do not need deoxyribonucleotides for genome replication. De- 
velopmental regulation of T. brucei ribonucleotide r ductase 
may occur at the post-transcriptional level as it has been sug- 
gested for other proteins of this parasite [25]. Alternatively the 
levels of the R1 and R2 transcripts are not linked as in Plas- 
modium falciparum [22] and R1 may be regulated. 
3.5. Outlook 
Ribonucleotide reductase is an attractive target molecule 
for anticancer and antimicrobial drug development [21,22]. 
The enzyme can be inhibited by nucleotide analogs, by reduc- 
tion of the essential tyrosyl radical nd by preventing subunit 
interaction [7,20,21]. In addition, interferring with the supply 
of reducing equivalents should strongly influence the activity 
of ribonucleotide r ductase. Since thioredoxin and glutaredox- 
in could not yet be detected in trypanosomatids ([1]; Krauth- 
Siegel et al., unpublished results) we will study if the unique 
dithiol trypanothione is the donor of reducing equivalents for 
the parasite ribonucleotide reduction. A link between the try- 
panothione and the deoxyribonucleotide m tabolisms would 
render inhibitors of trypanothione r ductase (TR) even more 
attractive as potential antiparasitic drugs [26] and nicely fit to 
the finding that TR is essential for parasite development 
[27,28]. 
Note: Recently the sequences of the RI and R2 subunits of 
T. brucei ribonucleotide reductase have been published [29]. 
There are two discrepancies between the deduced protein se- 
quences of the R2 protein. Arg8 and Lys43 (this paper) cor- 
respond to Cys8 and Glu43 [29], respectively. Both differences 
represent single base exchanges. 
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